antimicrobial agent in soap

PreclinicalSmall molecule

CCenters for Disease Control and Prevention

antimicrobial agent in soap is one of 3 small molecule programs targeting Lymphedema. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

LymphedemaActive, not recruiting

LymphedemaPreclinical

Active, not recruiting

Competition

Competitive Landscape

3 competitors in Lymphedema

#DrugCompanyPhaseTrials

Acebilustat

SStanford University

Phase 2

1 2

GLP-1 Receptor Agonists

JJinling Hospital, China

Phase 1

1 3

antimicrobial agent in soap

CCenters for Disease Control and Prevention

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Lymphedema1 trial

Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area

Completed·CCenters for Disease Control and Prevention·N/A·NCT00139100·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for antimicrobial agent in soap. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — antimicrobial agent in soap compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for antimicrobial agent in soap. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Centers for Disease Control and Prevention company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCenters for Disease Control and Prevention

antimicrobial agent in soap

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Lymphedema1 trial

References

Drug Info

Quick Facts

Related News